Natalie H. Bzowej, MD

 

Assistant Professor of Clinical Medicine

Ochsner Medical Center

1514 Jefferson Hwy

New Orleans, LA 70121

Phone: (504) 842-4015

 

Degree

MD - 1992

University of Toronto Medical School

Bio

 

 

 

 

Clinical Interests

 

Dr. Bowej received her doctor of medicine from the University of Toronto Medical School in Canada in 1992. She completed her residency in Internal Medicine at Wellesley Hospital, Toronto in 1994 and Toronto Hospital in 1995. Her fellowship in Gastroenterology was completed at the UNiversity of California Hospital in San Francisco which she completed in 1998. Dr. Bzowej is board certified by the American Board of Internal Medicine (ABIM) in 1998; by ABIM-Gastroenterology in 2001; by ABIM-Transplant Hepatology in 2008. Dr. Bzowej was Director of Clinical Hepatology  Research, Liver Transplant Program at the California Pacific Medical Center in San Francisco, CA.

 

Hepatology

Liver Transplant

Selected Publications

1. Bohorquez H, Seal JB, Cohen AJ, Kressel A, Bugeaud E, Bruce DS, Carmody IC, Reichman TW, Battula N, Alsaggaf M, Therapondos G, Bzowej N, Tyson G, Joshi S, Nicolau-Raducu R, Girgrah N, Loss GE. Safety and Outcomes in 100 Consecutive Donation After Circulatory Death Liver Transplants Using a Protocol That Includes Thrombolytic Therapy. Am J Transplant. 2017 Aug;17(8):2155-2164. Epub 2017 Apr 11. PMID: 28276658

2. Levitsky J, Verna EC, O'Leary JG, Bzowej NH, Moonka DK, Hyland RH, Arterburn S, Dvory-Sobol H, Brainard DM, McHutchison JG, Terrault NA. Perioperative Ledipasvir-Sofosbuvir for HCV in Liver-Transplant Recipients.N Engl J Med. 2016 Nov 24;375(21):2106-2108. PMID: 27959735         

3. Park JJ, Wong DK, Wahed AS, Lee WM, Feld JJ, Terrault N, Khalili M, Sterling RK, Kowdley KV, Bzowej N, Lau DT, Kim WR, Smith C, Carithers RL, Torrey KW, Keith JW, Levine DL, Traum D, Ho S, Valiga ME, Johnson GS, Doo E, Lok AS, Chang KM; Hepatitis B Research Network. Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B. Gastroenterology. 2016 Mar;150(3):684-695. Epub 2015 Dec 10. PMID: 26684441

4. Curry MP, O'Leary JG, Bzowej N, Muir AJ, Korenblat KM, Fenkel JM, Reddy KR, Lawitz E, Flamm SL, Schiano T, Teperman L, Fontana R, Schiff E, Fried M, Doehle B, An D, McNally J, Osinusi A, Brainard DM, McHutchison JG, Brown RS Jr, Charlton M; ASTRAL-4 Investigators. Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis.  N Engl J Med. 2015 Dec 31;373(27):2618-28. Epub 2015 Nov 16. PMID: 26569658

5. Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH; American Association for the Study of Liver Diseases. AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2016 Jan;63(1):261-83. Epub 2015 Nov 13. No abstract available. PMID: 26566064

6. Muir AJ, Arora S, Everson G, Flisiak R, George J, Ghalib R, Gordon SC, Gray T, Greenbloom S, Hassanein T, Hillson J, Horga MA, Jacobson IM, Jeffers L, Kowdley KV, Lawitz E, Lueth S, Rodriguez-Torres M, Rustgi V, Shemanski L, Shiffman ML, Srinivasan S, Vargas HE, Vierling JM, Xu D, Lopez-Talavera JC, Zeuzem S; EMERGE study group. A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection. J Hepatol. 2014 Dec;61(6):1238-46. Epub 2014 Jul 24. PMID: 25064437

7. Flamm SL, Muir AJ, Fried MW, Reddy KR, Nelson DR, Bzowej NH, Sullivan JC, Bengtsson L, DeMasi R, Wright CI, Kieffer TL, George S, Adda N, Dusheiko GM. Sustained virologic response rates with telaprevir-based therapy in treatment-naive patients evaluated by race or ethnicity. J Clin Gastroenterol. 2015 Apr;49(4):336-44. PMID: 24828357

8. Therapondos G, Bohorquez H, Bruce DS, Bzowej NH, Carmody IC, Cohen AJ, Girgrah N, Joshi S, Reichman TW, Loss GE Jr. Liver transplantation at the ochsner clinic: quality and outcomes improvement. Ochsner J. 2013 Fall;13(3):413-8. Review. PMID: 24052774

9. Holt EW, Guy J, Gordon SM, Hofmann JC, Garcia-Kennedy R, Steady SL, Bzowej NH, Frederick RT. Acute liver failure caused by herpes simplex virus in a pregnant patient: is there a potential role for therapeutic plasma exchange? J Clin Apher. 2013 Dec;28(6):426-9. Epub 2013 Jul 16.PMID: 23857723

10. Lawitz E, Lalezari JP, Hassanein T, Kowdley KV, Poordad FF, Sheikh AM, Afdhal NH, Bernstein DE, Dejesus E, Freilich B, Nelson DR, Dieterich DT, Jacobson IM, Jensen D, Abrams GA, Darling JM, Rodriguez-Torres M, Reddy KR, Sulkowski MS, Bzowej NH, Hyland RH, Mo H, Lin M, Mader M, Hindes R, Albanis E, Symonds WT, Berrey MM, Muir A. Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial. Lancet Infect Dis. 2013 May;13(5):401-8. Epub 2013 Mar 15. PMID: 23499158

11. Teperman LW, Poordad F, Bzowej N, Martin P, Pungpapong S, Schiano T, Flaherty J, Dinh P, Rossi S, Subramanian GM, Spivey J. Randomized trial of emtricitabine/tenofovir disoproxil fumarate after hepatitis B immunoglobulin withdrawal after liver transplantation. Liver Transpl. 2013 Jun;19(6):594-601. Epub 2013 Apr 9. PMID: 23447407

12. Wedemeyer H, Jensen D, Herring R Jr, Ferenci P, Ma MM, Zeuzem S, Rodriguez-Torres M, Bzowej N, Pockros P, Vierling J, Ipe D, Munson ML, Chen YC, Najera I, Thommes J; PROPEL Investigators. PROPEL: a randomized trial of mericitabine plus peginterferon alpha-2a/ribavirin therapy in treatment-naïve HCV genotype 1/4 patients. Hepatology. 2013 Aug;58(2):524-37. Epub 2013 Jun 26. PMID: 23348636

13. Afdhal NH, Giannini EG, Tayyab G, Mohsin A, Lee JW, Andriulli A, Jeffers L, McHutchison J, Chen PJ, Han KH, Campbell F, Hyde D, Brainsky A, Theodore D; ELEVATE Study Group. Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia. N Engl J Med. 2012 Aug 23;367(8):716-24. PMID:22913681

14. Bzowej NH. Optimal Management of the Hepatitis B Patient Who Desires Pregnancy or Is Pregnant. Curr Hepat Rep. 2012 Jun;11(2):82-89. Epub 2012 May 26. PMID:22707918

15. Wong RJ, Gish R, Frederick T, Bzowej N, Frenette C. The impact of race/ethnicity on the clinical epidemiology of autoimmune hepatitis.J Clin Gastroenterol. 2012 Feb;46(2):155-61. PMID:21814143